{
    "title": "Eli Lilly prepares for as many as 5 new drug launches next year",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11533481/Eli-Lilly-2023-profit-view-disappoints-higher-costs-strong-dollar.html",
    "date": "2022-12-13",
    "keywords": [
        "year",
        "obesity",
        "leo",
        "marketing",
        "research",
        "development",
        "donanemab",
        "profit",
        "type",
        "drug",
        "company",
        "dec",
        "tuesday",
        "growth",
        "decade",
        "multibillion",
        "dollar",
        "drugmaker",
        "release",
        "tirzepatide",
        "spending",
        "companys",
        "health",
        "approval",
        "brand",
        "name",
        "kind",
        "executive",
        "david",
        "bowel",
        "disease",
        "lebrikizumab",
        "atopic",
        "dermatitis",
        "cancer",
        "revenue",
        "street",
        "forecast",
        "share",
        "covid19",
        "antibody",
        "food",
        "administration",
        "authorization",
        "therapy",
        "bebtelovimab",
        "month",
        "reporting",
        "bengaluru",
        "editing",
        "syamnath",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}